Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.51 |
| ▸ | RAB9A | P51151 | 5/20 | 0.51 |
| ▸ | NPC1 | O15118 | 4/20 | 0.51 |
| ▸ | HTT | P42858 | 4/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.51 |
| ▸ | AGTR1 | P30556 | 3/20 | 0.51 |
| ▸ | GPR55 | Q9Y2T6 | 3/20 | 0.51 |
| ▸ | XBP1 | P17861 | 3/20 | 0.51 |
| ▸ | MDM2 | Q00987 | 3/20 | 0.51 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 4/20 | 0.49 |
| ▸ | RECQL | P46063 | 2/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.49 |
| ▸ | TERT | O14746 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25363305 | 1.00 | MAPT (0.51) | MAPTRAB9ANPC1HTTMAPK1 | |
| SCHEMBL9975665 | 0.90 | MAPT (0.48) | MAPTRAB9ANPC1HTTMAPK1 | |
| SCHEMBL30555815 | 0.88 | MAPT (0.64) | MAPTRAB9ANPC1HTTMAPK1 | |
| Brevilin A SCHEMBL27014668 | 0.84 | MAPT (0.52) | MAPTRAB9ANPC1HTTMAPK1 | |
| Brevilin A SCHEMBL27014670 | 0.84 | MAPT (0.52) | MAPTRAB9ANPC1HTTMAPK1 | |
| SCHEMBL27014666 | 0.84 | MAPT (0.55) | MAPTRAB9ANPC1HTTMAPK1 | |
| SCHEMBL30151485 | 0.81 | MAPT (0.58) | MAPTRAB9ANPC1HTTMAPK1 | |
| SCHEMBL6423690 | 0.81 | MAPT (0.58) | MAPTRAB9ANPC1HTTMAPK1 | |
| SCHEMBL30899614 | 0.81 | MAPT (0.58) | MAPTRAB9ANPC1HTTMAPK1 | |
| SCHEMBL27014729 | 0.78 | MAPT (0.51) | MAPTRAB9ANPC1HTTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250032385-A1 | FUNCTIONAL COMPOSITION FOR ALOPECIA COMPRISING CENTIPEDA MINIMA-DERIVED EXTRACT | D-NATURE CO., LTD. (KR) | 2025-01-30 | — | — | US | claimed |
| WO-2024123024-A1 | COMPOSITION INCLUDING CENTIPEDA MINIMA EXTRACT FOR PREVENTION AND TREATMENT OF INFLAMMATION AND AUTOIMMUNE DISEASES AND MANUFACTURING METHOD THEREFOR | 주식회사 디네이쳐 | 2024-06-13 | — | — | WO | claimed |
| EP-4344696-A1 | FUNCTIONAL COMPOSITION FOR ALOPECIA COMPRISING CENTIPEDA MINIMA-DERIVED EXTRACT | D-Nature Co., Ltd. (KR) | 2024-04-03 | — | — | EP | claimed |
| US-20240016779-A1 | COMPOSITION FOR PREVENTING AND TREATING INFLAMMATORY DISEASE AND AUTOIMMUNE DISEASES AND NON-ALCOHOLIC FATTY LIVER DISEASE, COMPRISING EXTRACT DERIVED FROM CENTIPEDA MINIMA | D-NATURE CO., LTD. (KR) | 2024-01-18 | — | — | US | claimed |
| EP-4230214-A1 | COMPOSITION FOR PREVENTING AND TREATING ANTI-INFLAMMATORY AND AUTOIMMUNE DISEASES AND NON-ALCOHOLIC FATTY LIVER DISEASE, COMPRISING EXTRACT DERIVED FROM CENTIPEDA MINIMA | D-Nature Co., Ltd. (KR) | 2023-08-23 | — | — | EP | claimed |
| WO-2023277616-A1 | FUNCTIONAL COMPOSITION FOR ALOPECIA COMPRISING CENTIPEDA MINIMA-DERIVED EXTRACT | 주식회사 디네이쳐 | 2023-01-05 | — | — | WO | claimed |
| WO-2022092523-A1 | COMPOSITION FOR PREVENTING AND TREATING ANTI-INFLAMMATORY AND AUTOIMMUNE DISEASES AND NON-ALCOHOLIC FATTY LIVER DISEASE, COMPRISING EXTRACT DERIVED FROM CENTIPEDA MINIMA | 주식회사 디네이쳐 | 2022-05-05 | — | — | WO | claimed |
| US-20250032385-A1 | FUNCTIONAL COMPOSITION FOR ALOPECIA COMPRISING CENTIPEDA MINIMA-DERIVED EXTRACT | D-NATURE CO., LTD. (KR) | 2025-01-30 | — | — | US | disclosed |
| US-20250032385-A1 | FUNCTIONAL COMPOSITION FOR ALOPECIA COMPRISING CENTIPEDA MINIMA-DERIVED EXTRACT | D-NATURE CO., LTD. (KR) | 2025-01-30 | — | — | US | disclosed |
| CN-118924802-A | Preparation of Centipeda minima ethanol extract for promoting killing CD8+Application of T cell infiltration solid tumor medicine | 广州中医药大学(广州中医药研究院) | 2024-11-12 | — | — | CN | disclosed |
| WO-2024123024-A1 | COMPOSITION INCLUDING CENTIPEDA MINIMA EXTRACT FOR PREVENTION AND TREATMENT OF INFLAMMATION AND AUTOIMMUNE DISEASES AND MANUFACTURING METHOD THEREFOR | 주식회사 디네이쳐 | 2024-06-13 | — | — | WO | disclosed |
| WO-2024123024-A1 | COMPOSITION INCLUDING CENTIPEDA MINIMA EXTRACT FOR PREVENTION AND TREATMENT OF INFLAMMATION AND AUTOIMMUNE DISEASES AND MANUFACTURING METHOD THEREFOR | 주식회사 디네이쳐 | 2024-06-13 | — | — | WO | disclosed |
| EP-4344696-A1 | FUNCTIONAL COMPOSITION FOR ALOPECIA COMPRISING CENTIPEDA MINIMA-DERIVED EXTRACT | D-Nature Co., Ltd. (KR) | 2024-04-03 | — | — | EP | disclosed |
| EP-4230214-A1 | COMPOSITION FOR PREVENTING AND TREATING ANTI-INFLAMMATORY AND AUTOIMMUNE DISEASES AND NON-ALCOHOLIC FATTY LIVER DISEASE, COMPRISING EXTRACT DERIVED FROM CENTIPEDA MINIMA | D-Nature Co., Ltd. (KR) | 2023-08-23 | — | — | EP | disclosed |
| CN-116472038-A | Composition for anti-inflammatory and preventing and treating autoimmune diseases and nonalcoholic fatty liver diseases comprising Centipeda minima-derived extract | D-自然株式会社 | 2023-07-21 | — | — | CN | disclosed |
| CN-116472038-A | Composition for anti-inflammatory and preventing and treating autoimmune diseases and nonalcoholic fatty liver diseases comprising Centipeda minima-derived extract | D-自然株式会社 | 2023-07-21 | — | — | CN | disclosed |
| WO-2023277616-A1 | FUNCTIONAL COMPOSITION FOR ALOPECIA COMPRISING CENTIPEDA MINIMA-DERIVED EXTRACT | 주식회사 디네이쳐 | 2023-01-05 | — | — | WO | disclosed |
| WO-2023277616-A1 | FUNCTIONAL COMPOSITION FOR ALOPECIA COMPRISING CENTIPEDA MINIMA-DERIVED EXTRACT | 주식회사 디네이쳐 | 2023-01-05 | — | — | WO | disclosed |
| WO-2022092523-A1 | COMPOSITION FOR PREVENTING AND TREATING ANTI-INFLAMMATORY AND AUTOIMMUNE DISEASES AND NON-ALCOHOLIC FATTY LIVER DISEASE, COMPRISING EXTRACT DERIVED FROM CENTIPEDA MINIMA | 주식회사 디네이쳐 | 2022-05-05 | — | — | WO | disclosed |
| WO-2022092523-A1 | COMPOSITION FOR PREVENTING AND TREATING ANTI-INFLAMMATORY AND AUTOIMMUNE DISEASES AND NON-ALCOHOLIC FATTY LIVER DISEASE, COMPRISING EXTRACT DERIVED FROM CENTIPEDA MINIMA | 주식회사 디네이쳐 | 2022-05-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250032385-A1 | FUNCTIONAL COMPOSITION FOR ALOPECIA COMPRISING CENTIPEDA MINIMA-DERIVED EXTRACT | BTN3A1, NGF, BBC3 | MAPT 2816/4885RAB9A 3932/4885NPC1 4459/4885 |
| US-20240016779-A1 | COMPOSITION FOR PREVENTING AND TREATING INFLAMMATORY DISEASE AND AUTOIMMUNE DISEASES AND NON-ALCOHOLIC FATTY LIVER DISEASE, COMPRISING EXTRACT DERIVED FROM CENTIPEDA MINIMA | FABP1, CHIA, SSB | MAPT 3944/4885RAB9A 3223/4885NPC1 2789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.